|
|
|
|
| LEADER |
02620nmm a2200289 u 4500 |
| 001 |
EB001083284 |
| 003 |
EBX01000000000000000842691 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
151019 ||| eng |
| 100 |
1 |
|
|a Evans, Tracey L.
|
| 245 |
0 |
0 |
|a Bevacizumab
|h Elektronische Ressource
|b the first FDA-approved angiogenesis inhibitor in the treatment of non-small cell lung cancer
|c Tracey Evans
|
| 260 |
|
|
|a London
|b Henry Stewart Talks
|c 2009, 2009
|
| 300 |
|
|
|a 1 online resource (1 streaming video file (54 min.)
|b color, sound)
|
| 505 |
0 |
|
|a Lung cancer incidence -- Survival by treatment group -- Selected trials of novel agents + chemotherapy -- Bevacizumab -- Vascular Endothelial Growth Factor (VEGF) -- Principles of angiogenesis -- Bevacizumab in NSCLC: not for everybody -- Randomized phase II trial of Paclitaxel/Carboplatin with/without Bevacizumab in NSCLC -- Hemorrhagic events -- Example of tumor cavitation in lung following treatment with chemotherapy and Bevacizumab -- Patient haracteristics -- Response rates -- Hematologic and non-hematologic toxicity -- Treatment related deaths -- Efficacy by gender and age -- NCCN pactice guidelines in oncology-v.2.2008 -- AVAiL: phase III trial of Bevacizumab + Gemcitabine and Cisplatin in advanced non|squamous cell NSCLC -- Second line therapy for advanced NSCLC: the role of Bevacizumab -- Adjuvant therapy in NSCLC -- Can a broader range of patients be safely treated with Bevacizumab? -- Protocol AVF3744g: BRIDGE trial
|
| 653 |
|
|
|a Neoplasms / therapy
|
| 653 |
|
|
|a Angiogenesis Inhibitors / therapeutic use
|
| 653 |
|
|
|a Neoplasms / complications
|
| 653 |
|
|
|a Lung Neoplasms / drug therapy
|
| 653 |
|
|
|a Carcinoma, Non-Small-Cell Lung / drug therapy
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b HST
|a Henry Stewart Talks
|
| 490 |
0 |
|
|a Cancer therapy : latest thinking in efficacy and toxicity
|
| 500 |
|
|
|a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web. - System requirements: Browser compatibility: updated Mozilla Firefox, Google Chrome, Safari or Internet Explorer 8+. Browser settings: enable JavaScript, enable cookies from the Henry Stewart Talks site. Required Desktop Browser plugins & viewers: Updated Adobe Flash Player & Adobe Acrobat Reader. Mobile device & operating system versions: Android v4.0+, iPhone 4+ (iOS v6.x+), iPad 2+ (iOS v6.x+), BlackBerry OS v7.0+, Windows Phone v6.5.1+
|
| 856 |
4 |
2 |
|u https://hstalks.com/bs/p/385
|3 Series
|
| 856 |
4 |
0 |
|u https://hstalks.com/bs/1113
|x Verlag
|z Streaming video file
|
| 082 |
0 |
|
|a 570
|